Get started
Author

Abdullah Alsulaiman

Observed names: Abdullah A. Alsulaiman, Abdullah Al Sulaiman
ORCID: 0009-0003-5204-8102
Observed ORCID: 0009-0003-5204-8102
OpenAlex ID: A5134522152
The efficacy of standard‐dose versus reduced‐dose everolimus in patients with advanced neuroendocrine tumors: A multicenter retrospective cohort study
2026 · Oudai Sahwan, Amr Mohamed, et al. · Journal of Neuroendocrinology
Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis
2026 · Wallace Klein Schwengber, Fares Jamal, et al. · Cancer Treatment Reviews
Neutropenic Diet Versus Liberalized Diet in Patients With Cancer: A Systematic Review and Meta-Analysis
2026 · Fares Jamal, Ayla Kouli, et al. · JCO Oncology Practice
Early hypoalbuminemia during zolbetuximab therapy in gastroesophageal adenocarcinoma: a retrospective observational study
2026 · Fares Jamal, Cody Eslinger, et al. · Journal of Gastrointestinal Oncology
Germline Cancer Testing in Unselected Patients With Neuroendocrine Neoplasms: A Multicenter Prospective Study
2026 · Oluseyi Abidoye, Michael Golafshar, et al. · Pancreas
Access to Immunotherapy and Molecular Diagnostics for Lung Adenocarcinoma in Syria: A Mixed-Methods Study from the Country’s Main Cancer Center
2026 · Ayla Kouli, Fares Jamal, et al. · Avicenna Journal of Medicine
Neutropenic diet (ND) versus liberalized diet (LD) in patients with cancer: A systematic review and meta-analysis.
2026 · Fares Jamal, Ayla Kouli, et al. · Journal of Clinical Oncology
Real-world access to molecular diagnostics and immunotherapy for advanced melanoma in Syria.
2026 · Ayla Kouli, Fatima Al-Jojo, et al. · Journal of Clinical Oncology
Time to treatment initiation (TTI) and survival outcomes in metastatic extrapulmonary neuroendocrine carcinoma (EP-NEC).
2026 · Abdullah Alsulaiman, Fares Jamal, et al. · Journal of Clinical Oncology
Reduced oxaliplatin exposure in gastrointestinal cancers: A systematic review and meta-analysis.
2026 · Wallace Klein Schwengber, Fares Jamal, et al. · Journal of Clinical Oncology
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma
2026 · Fares Jamal, Oudai Sahwan, et al. · JCO Precision Oncology
Leveraging large language models (LLM) to guide adjuvant chemotherapy (AC) recommendations in stage III colorectal cancer (CRC).
2026 · Arshad Mohammed, Fares Jamal, et al. · Journal of Clinical Oncology
Impact of infusion timing (IT) on survival outcomes across gastrointestinal (GI) malignancies: A multicenter analysis of circadian rhythm (CR) effects on immune checkpoint inhibitor (ICI) activity.
2026 · Fares Jamal, Amal Youssef, et al. · Journal of Clinical Oncology
Reduced Oxaliplatin Exposure in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis
2026 · Wallace Klein Schwengber, Fares Jamal, et al. · SSRN Electronic Journal
Biomarker-Driven Precision Oncology in Advanced Gastroesophageal Adenocarcinoma: Current Standards and Future Directions
2026 · Fares Jamal, Abdullah Alsulaiman, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
PDF
Homologous Recombination Deficiency as a Biomarker for Chemoimmunotherapy Benefit in Advanced Biliary Tract Cancer: A Multicenter Retrospective Cohort Study
2026 · Oluseyi Abidoye, Heidi Kosiorek, et al. · SSRN Electronic Journal
Works count: 16
Citation count:
H-index:
I10-index:
Year
Topic
Type